TCRX TScan Therapeutics, Inc. Common Stock BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

TScan Therapeutics (TCRX) Stock: Buy, Sell, or Hold?

$0.18
-0.01 (-3.89%) β–Ό
5d: -15.24% 30d: -17.86% 90d: -76.94%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (90%)
Quality Score
58/100
Position
OVERSOLD
30-Day Fair Range
$0.18 – $0.24
Position: OVERSOLD
Forward P/E & Valuation
-0.3x
Next 12M consensus est.
Wall Street Target
$1.00
+440.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.17 / $0.21
Trend: Strong Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: TCRX is down 15.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When TCRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: TCRX is currently trading at $0.18, which is considered oversold relative to its 30-day fair value range of $0.18 to $0.24.

Technical Outlook: Technically, TCRX is in a strong downtrend. Immediate support is located at $0.17, while resistance sits at $0.21. Short-term momentum is weak, with the stock down 3.9% recently.

Market Sentiment: TCRX scores 83/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.00 (+440.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.18 - $0.24
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 89.5%

Trading Range & Key Levels

30-Day Trading Range $0.18 - $0.24
Current vs Trading Range OVERSOLD
Support Level $0.17
Resistance Level $0.21
Current Trend Strong Downtrend
Technical data as of Nov 10, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (83/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.9%)
  • BULLISH: Trading 440.0% below Wall St target ($1.00)
  • BULLISH: Bottoming setup score 83/100 β€” corrected, stabilizing, and turning up
  • WARNING: Recommendation downgraded due to -15.2% 5-day decline - wait for stabilization

Fundamental Context

Forward P/E (Next Year Est.) -0.32
Wall Street Target $1.00 (+440.0%)
Revenue Growth (YoY) -65.8%
Share TCRX Analysis

Share this live TCRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (TCRX)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages indicate a bullish sentiment towards $TCRX, with no recent news articles available.
Key Retail Themes: Trader optimism Lack of news
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:58 AM ET
Data refreshes hourly during market hours. Next update: 10:58 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for TCRX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
28 analysts
$91 51 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
22 analysts
$266 60 HOLD
INCY
Incyte Corporation
HOLD
28 analysts
$132 53 HOLD
RAPP
Rapport Therapeutics, In…
STRONG BUY
16 analysts
$64 58 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
22 analysts
$107 41 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive TCRX Research Pages
TCRX Technical Chart TCRX Price Prediction TCRX Intrinsic Value DCF TCRX Earnings Date TCRX Investment Advisor TCRX Fair Price Analyzer TCRX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals